McGill University Health Centre ( Site 0100)

Montreal, Quebec H9H 4M7

1 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Non-small Cell Lung Cancer, Ovarian Cancer Recurrent

Studies at this site

• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) — Recruiting now
• A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) — Recruiting now
• Efficacy and Safety Study of Pembrolizumab (MK-3475) in Combination With Daratumumab in Participants With Relapsed Refractory Multiple Myeloma (MK-3475-668/KEYNOTE-668) — Withdrawn before enrolling